Brought to you by:
New data show single-session Indigo aspiration system without overnight thrombolytics is safe and effective for patients with ALI
During the Society of Interventional Radiology (SIR) 2024 annual meeting (23–28 March, Salt Lake City, USA), newly presented data from a subgroup analysis of the STRIDE study showed that Penumbra’s Indigo aspiration system used in a single session without the…
SVS announces VAM keynote speaker series
Registration for the 2024 Vascular Annual Meeting (VAM 2024) launched on March 20 and promotions teased a new annual VAM fixture: the SVS Keynote Speaker Series. The inaugural address will take place in Chicago on Wednesday, June 19, and will…
Study hints at long-term cost-effectiveness of CDT and PMT over oral anticoagulation for moderate and severe PTS
During a presentation at the 2024 European Vascular Course (EVC; March 3–5) in Maastricht, The Netherlands, Anna Pouncey, MD, a clinical research fellow for vascular surgery at Imperial College London in London, England, presented findings from a study on the…
Getinge and Cook Medical enter US commercial distribution agreement for iCast covered stent
Getinge and Cook Medical today announced an exclusive sales and distribution agreement for the iCast covered stent system, which recently received Food and Drug Administration (FDA) premarket approval for the treatment of symptomatic iliac arterial occlusive disease. Cook Medical will…
First-in-human study of Pounce thrombectomy system in acute iliofemoral DVT demonstrates 12-month PTS rate of 18%
Twelve-month outcomes from the Pounce venous thrombectomy system (Vetex Medical) first-in-human study evaluating its use in the treatment of acute iliofemoral deep vein thrombosis (DVT) recently published in the Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL) demonstrated an…
Endovascular showdown: CX 2024 sets the stage for BASIL-3 first-time data presentations
At the Charing Cross (CX) Symposium 2024 (23–25 April, London, UK), Andrew Bradbury (University of Birmingham, Birmingham, UK) and the BASIL-3 team of triallists will address the pressing question of which endovascular strategy wins in the disputed femoropopliteal segment. The…
FDA Breakthrough Device designation granted for DynamX BTK for use in CLTI treatment below the knee
Elixir Medical has announced Breakthrough Device designation by the Food and Drug Administration (FDA) for its novel DynamX BTK System, an implant for use in the treatment of narrowed or blocked vessels below-the-knee (BTK) in patients with chronic limb-threatening ischemia…
Personalized, precision medicine is key to the future of aortic repair
Predicting longevity in patients who may be candidates for aortic repair is challenging. This, coupled with a high and unchanging long-term postoperative mortality rate, begs the question: are patients living long enough to benefit from aortic repair? Bijan Modarai (King’s…
Bentley, Cook Medical enter US distribution agreement for BeBack device
Cook Medical and Bentley today announced a distribution agreement for the BeBack crossing catheter in the U.S., with Cook assuming commercial responsibilities for the Bentley product in the coming months. The BeBack device is designed for steering through chronic total…
SCVS 2024: Bismuth becomes 2024–25 Society for Clinical Vascular Surgery president
Jean Bismuth, MD, took over as Society for Clinical Vascular Surgery (SCVS) president during the organization’s 51st Annual Symposium in Scottsdale, Arizona (March 16–20). The new University of South Florida chief of vascular surgery followed M. Ashraf Mansour, MD, academic…